Procarbazine

CHEMBL1321 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
221.3 g/mol
LogP
0.1
Phase
4

A chemotherapy medication used primarily as part of combination regimens to treat Hodgkin's lymphoma and certain brain tumors by interfering with DNA replication to prevent cancer cells from dividing. It requires dietary restrictions similar to MAO inhibitors and can interact with many foods and medications.

Khối lượng phân tử

221,3000 g/mol

LogP

0,10

TPSA

53,20 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CNNCc1ccc(C(=O)NC(C)C)cc1

InChI

InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16)

Molecular Formula

C12H19N3O

HBD / HBA

3 / 3

Liên kết có thể quay

5

Nguyên tử nặng

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A chemotherapy medication used primarily as part of combination regimens to treat Hodgkin's lymphoma and certain brain tumors by interfering with DNA replication to prevent cancer cells from dividing. It requires dietary restrictions similar to MAO inhibitors and can interact with many foods and medications.

Yes, Procarbazine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1321. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4915. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.